Urology · Sherman Oaks, CA
NPI
1427158245
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
5522 Sepulveda Blvd
Sherman Oaks, CA, 91411
Phone (818) 990-5020
Groups this clinician bills Medicare through
Medicare paid, 2024
$744K
56,812 services
Medicare patients, 2024
833
Average age 76
Drug cost, 2024
$826K
2,259 prescriptions
Company payments, 2025
$20K
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard D David was code J1071 (injection, testosterone cypionate, 1 mg), 14,234 times for 12 patients. In total Richard D David billed 56,812 services in 125 codes, and Medicare paid $744K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 14,234 | 12 | $0.02 | $293 |
| 81001 Clinical Chemistry | Office | 2,059 | 768 | $3.10 | $6,379 |
| 82570 Clinical Chemistry | Office | 2,051 | 768 | $5.06 | $10K |
| 99214 Office E&M - Established | Office | 1,722 | 702 | $108.08 | $186K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,696 | 730 | $14.22 | $24K |
| 36415 Venipuncture Blood Collection | Office | 896 | 447 | $8.25 | $7,393 |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 705 | 391 | $95.21 | $67K |
| 84153 Clinical Chemistry | Office | 690 | 372 | $17.85 | $12K |
| 87184 General Laboratory | Office | 512 | 218 | $7.28 | $3,728 |
| 84403 Clinical Chemistry | Office | 466 | 207 | $25.08 | $12K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 421 | 70 | $54.48 | $23K |
| 87086 Bacterial Culture | Office | 410 | 258 | $7.88 | $3,230 |
| 87077 Bacterial Culture | Office | 406 | 187 | $7.88 | $3,199 |
| 99213 Office E&M - Established | Office | 351 | 241 | $74.73 | $26K |
| 96372 Injection Administration | Office | 342 | 77 | $13.08 | $4,473 |
By year: 2022 $751K for 49,327 services; 2023 $972K for 37,004 services; 2024 $744K for 56,812 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 2,059 | 768 | $3.10 | $6,379 |
| 82570 Clinical Chemistry | 2,051 | 768 | $5.06 | $10K |
| 36415 Venipuncture Blood Collection | 896 | 447 | $8.25 | $7,393 |
| 84153 Clinical Chemistry | 690 | 372 | $17.85 | $12K |
| 87184 General Laboratory | 512 | 218 | $7.28 | $3,728 |
| 84403 Clinical Chemistry | 466 | 207 | $25.08 | $12K |
| 87086 Bacterial Culture | 410 | 258 | $7.88 | $3,230 |
| 87077 Bacterial Culture | 406 | 187 | $7.88 | $3,199 |
| 84402 Clinical Chemistry | 339 | 170 | $24.75 | $8,392 |
| 84270 Clinical Chemistry | 338 | 169 | $21.12 | $7,140 |
Medicare prescription drug claims, 2024
In 2024, the drug Richard D David prescribed most often to Medicare patients was Gemtesa (Vibegron), with 233 prescriptions and refills. In total Richard D David wrote 2,259 Medicare prescriptions that cost $826K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gemtesa Vibegron | 233 | 377 | 66 | $178K |
| Dutasteride Generic | 224 | 565 | 64 | $11K |
| Tamsulosin Hcl Generic | 217 | 499 | 64 | $2,969 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 203 | 530 | 60 | $5,859 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 132 | 132 | 114 | $2,432 |
| Finasteride Generic | 124 | 352 | 38 | $2,685 |
| Anastrozole Generic | 103 | 267 | 33 | $234 |
| Solifenacin Succinate Generic | 80 | 172 | 22 | $4,518 |
| Estradiol Generic | 57 | 136 | 29 | $3,719 |
| Myrbetriq Mirabegron | 57 | 103 | 19 | $48K |
| Tadalafil Generic | 53 | 93 | 11 | $892 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 52 | 67 | Under 11 | $654 |
| Levofloxacin Generic | 39 | 39 | 35 | $454 |
| Allopurinol Generic | 38 | 70 | Under 11 | $170 |
| Jatenzo Testosterone Undecanoate | 37 | 44 | Under 11 | $40K |
Brand drugs: 429 claims; generic drugs: 1,830 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard D David $20K ($20K in general payments such as food, travel and fees) from 30 companies. The largest payer was Accord Healthcare, Inc. with $7,410.
| Company | Payments | Amount |
|---|---|---|
| Accord Healthcare, Inc. | 5 | $7,410 |
| Astellas Pharma US Inc 4503.T | 6 | $6,598 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $3,243 |
| Sumitomo Pharma America, Inc. 4506.T | 17 | $324 |
| Janssen Biotech, Inc. JNJ | 6 | $296 |
| Pfizer Inc. PFE | 10 | $187 |
| Merck Sharp & Dohme LLC MRK | 6 | $179 |
| Abbvie Inc. ABBV | 11 | $160 |
| Telix Pharmaceuticals TLX | 7 | $156 |
| Dendreon Pharmaceuticals LLC | 8 | $138 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.